Stay updated on ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial

Sign up to get notified when there's something new on the ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This update signals a small backend/display adjustment and does not change the visible study details.
    Difference
    0.1%
    Check dated 2026-05-15T15:31:01.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer revision indicator is updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:41:12.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed references to non-alcoholic fatty liver disease (NAFLD) and related topics (e.g., MedlinePlus Genetics) from the page.
    Difference
    0.2%
    Check dated 2026-04-02T15:28:09.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:40:29.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:38.000Z thumbnail image

Stay in the know with updates to ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-801 Extension in Overweight/Obese NAFLD Subjects Clinical Trial page.